Summary
To evaluate the possible functional antagonism of the calcium antagonists diltiazem and verapamil of the sympathetic nervous system and the renin-angiotensin system, their influence on blood pressure, heart rate, plasma catecholamines and renin activity (PRA), and on the reaction of these parameters to exogenous noradrenaline (NA) and angiotensin II, was investigated in 8 normotensive volunteers. Intravenous diltiazem or verapamil caused a sharp, shortlasting decrease in systolic and diastolic blood pressure, with a maximum 1–3 min after injection and a duration of 10–15 min. Even a further infusion of the calcium antagonists was unable to maintain the initial hypotensive effect. The cessation of the hypotensive effect was not due to reflex stimulation of the sympathetic nervous system, as indicated by unchanged plasma NA and adrenaline levels in the case of diltiazem, but was associated with an increase in PRA. During the administration of diltiazem and verapamil, the increase in blood pressure in response to the infusion of NA and angiotensin II was attenuated; the increase in diastolic pressure was mainly affected. The inhibition was more pronounced at the higher infusion rate of NA and angiotensin II. On the basis of these findings it is suggest that the hypotensive activity of calcium antagonists can be at least partly attributed to a reduction in vascular tone which is maintained by the postjunctional action of noradrenaline and angiotensin II.
Similar content being viewed by others
References
Bender F (1970) Die Behandlung der tachykarden Arrhythmien und der arteriellen Hypertonie mit Verapamil. Arzneimittelforsch (Drug Res) 29: 1310–1316
Brittinger WD, Schwarzbeck A, Wittenmeier KW, Twittenhoff WD, Stegaru B, Huber H, Ewald RW, von Henning GE, Fabricius M, Strauch M (1970) Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von Verapamil. Dtsch Med Wochenschr 95: 1871–1877
Cavero I, Lefèvre-Borg F (1981) Effects of diltiazem and verapamil on pressor responses mediated by stimulation of alpha1-, alpha2-adrenoceptors, angiotensin II and 5-hydroxy-tryptamine receptors in pithed rats. Br J Pharmacol 74: 839
Corea L, Miele N, Bentivoglio M, Boschetti E, Agabiti-Rosei E, Muiesan C (1979) Acute and chronic effects of nifedipine on plasma renin activity and plasma adrenaline and noradrenaline in controls and hypertensive patients. Clin Sci 57: 115s-117s
DaPrada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomol range. Life Sci 19: 1161–1174
Elliott HL, Reid JL (1983) Evidence for postjunctional vascular alpha2-adrenoceptors in peripheral vascular regulation in man. Clin Sci 65: 237–241
Guazzi M, Olivari MT, Polese A, Fiorentini C, Magrini F, Moruzzi P (1977) Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22: 528–532
Hörtnagl H, Magometschnigg D, Prager J (1982) Hyperkinetic heart syndrome: the role of the sympathetic nervous system. Cardiology 69: 74–83
Langer SZ, Shepperson NB (1982) Recent developments in vascular smooth muscle pharmacology: the postsynaptic alpha2-adrenoceptor. Trends Pharmacol Sci 3: 440–444
Lederballe Pedersen O (1981) Calcium blockers as a therapeutic principle in arterial hypertension. Acta Pharmacol Toxicol 49 [Suppl 2]: 1–31
Lederballe Pedersen O, Christensen NJ, Rämsch KD (1980) Comparison of acute effects of nifedipine in normotensive and hypertensive man. J Cardiovasc Pharmacol 2: 357–366
Lewis GRJ (1982) The long-term management of hypertension with verapamil. Clin Exp Pharmacol Physiol [Suppl 6]: 107–112
McGrath JC (1982) Evidence for more than one type of postjunctional alpha-adrenoceptor. Biochem Pharmacol 31: 467–484
Mendelsohn FAO, Doyle AE, Gray GW (1980) Lack of response of sympathetic nervous system to angiotensin infusion. Lancet 1: 492–493
Millar JA, McLean K, Reid JL (1981) Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man. Clin Sci 61: 65s-68s
Nicholls MG, Espiner EA, Miles KD, Zweifler AJ, Julius S (1981) Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endocrinol 15: 423–430
Peuler JD, Johnson GA (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21: 625–636
Rowe BP, Nasjletti A (1981) The effect of angiotensin II infusion on plasma catecholamines in the conscious rabbit. Proc Soc Exp Biol Med 168: 110–113
Singh BN, Ellrodt G, Peter CT (1978) Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 15: 169–197
Starke K, Docherty JR (1981) alpha1- and alpha2-adrenoceptors: Pharmacology and clinical implications. J Cardiovasc Pharmacol 3 [Suppl 1]: s14–23
Timmermans PBMWM, VanZwieten PA (1981) The postsynaptic alpha2-adrenoceptor. J Auton Pharmac 1: 171–183
Van Brummelen P, Vermey P, Timmermans PBMWM, Van Zwieten PA (1982) Preliminary evidence for a postsynaptic alpha2-adrenoceptor in the vasculature of the human forearm. Br J Clin Pharmacol 15: 134P
Van Meel JCA, DeJonge A, Kalkman HO, Wilfert B, Timmermans PBMWM, Van Zwieten PA (1981) Vascular smooth muscle contraction initiated by postsynaptic alpha2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69: 205–208
Van Meel JCA, De Zoeten K, Timmermans PBMWM, Van Zwieten PA (1982) Impairment by nifedipine of vasopressor responses to stimulation of postsynaptic alpha2-adrenoceptors in ganglionblocked rabbits. Further evidence for the selective inhibition of postsynaptic alpha2-adrenoceptor-induced pressor responses by calcium antagonists. J Auton Pharmacol 2: 13–20
Van Meel JCA, Timmermans PBMWM, Van Zwieten PA (1983) Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha2-adrenoceptor-mediated vasopressor responses. Eur J Pharmacol 92: 27–34
Vierhapper H, Waldhäusl W (1982) Reduced pressor effect of angiotensin II and noradrenaline in normal man following the oral administration of the calcium antagonists nifedipine. Eur J Clin Invest 12: 263–267
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Magometschnigg, D., Hörtnagl, H. & Rameis, H. Diltiazem and verapamil: Functional antagonism of exogenous noradrenalin and angiotensin II in man. Eur J Clin Pharmacol 26, 303–307 (1984). https://doi.org/10.1007/BF00548759
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00548759